Tudor Investment Corp
ORIC icon

Tudor Investment Corp’s Oric Pharmaceuticals ORIC Stock Holding History

Tudor Investment Corp’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$427K Buy
+33,688
New +$382K ﹤0.01% 2919
2025
Q3 		– Sell
-33,530
Closed -$340K – 3726
2025
Q2 		$340K Sell
33,530
-1,755
-5% -$11.8K ﹤0.01% 2818
2025
Q1 		$197K Buy
+35,285
New +$309K ﹤0.01% 2871
2024
Q3 		– Sell
-33,391
Closed -$236K – 3000
2024
Q2 		$236K Buy
33,391
+4,186
+14% +$37.5K ﹤0.01% 2099
2024
Q1 		$402K Buy
+29,205
New +$347K ﹤0.01% 1743

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Tudor Investment Corp's ORIC Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 33,688 shares worth $427K. The stake represents ﹤0.01% of the portfolio and ranks #2919 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in ORIC as recently as Q2 2025.

Tudor Investment Corp first reported a position in ORIC in Q1 2024 and has held it in 5 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Tudor Investment Corp held 33,688 shares of Oric Pharmaceuticals worth $427K as of Q1 2026.
  • Oric Pharmaceuticals was a new Tudor Investment Corp position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2919 holding.
  • Tudor Investment Corp first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.